Float Short %

14.88

Margin Of Safety %

Put/Call OI Ratio

0.38

EPS Next Q Diff

0.06

EPS Last/This Y

0.42

EPS This/Next Y

0.32

Price

4.37

Target Price

14.67

Analyst Recom

1.29

Performance Q

-37.84

Upside

-828.8%

Beta

1.02

Ticker: EOLS

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-23	EOLS	4.91	0.22	0.44	7159
2026-01-26	EOLS	4.8	0.22	0.07	7221
2026-01-27	EOLS	4.95	0.22	0.42	7464
2026-01-28	EOLS	4.8	0.31	0.00	14133
2026-01-29	EOLS	4.65	0.31	0.04	14199
2026-01-30	EOLS	4.68	0.30	0.14	14404
2026-02-02	EOLS	4.91	0.30	0.02	14389
2026-02-03	EOLS	4.7	0.30	0.03	14358
2026-02-04	EOLS	4.6	0.31	0.21	14342
2026-02-05	EOLS	4.41	0.31	0.60	14414
2026-02-06	EOLS	4.49	0.31	0.00	14438
2026-02-09	EOLS	4.24	0.33	2.19	13501
2026-02-10	EOLS	4.45	0.38	0.00	13875
2026-02-11	EOLS	4.3	0.38	2.00	13910
2026-02-12	EOLS	4.28	0.38	0.19	14021
2026-02-13	EOLS	4.3	0.38	9.19	14022
2026-02-17	EOLS	4.39	0.39	0.00	14165
2026-02-18	EOLS	4.34	0.39	1.17	14259
2026-02-19	EOLS	4.42	0.38	0.17	14192
2026-02-20	EOLS	4.36	0.38	999.99	14329
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-23	EOLS	4.91	313.7	36.6	-0.39
2026-01-26	EOLS	4.80	313.7	36.6	-0.39
2026-01-27	EOLS	4.94	313.7	36.5	-0.39
2026-01-28	EOLS	4.80	313.7	36.6	-0.39
2026-01-29	EOLS	4.64	313.7	36.6	-0.39
2026-01-30	EOLS	4.69	313.7	36.5	-0.39
2026-02-02	EOLS	4.91	313.7	36.5	-0.39
2026-02-03	EOLS	4.70	313.7	36.6	-0.39
2026-02-04	EOLS	4.60	313.7	36.6	-0.39
2026-02-05	EOLS	4.42	313.7	14.2	-0.39
2026-02-06	EOLS	4.49	313.7	13.3	-0.39
2026-02-09	EOLS	4.24	151.8	14.5	-0.39
2026-02-10	EOLS	4.45	151.8	12.8	-0.39
2026-02-11	EOLS	4.30	151.8	14.2	-0.39
2026-02-12	EOLS	4.29	151.8	13.6	-0.39
2026-02-13	EOLS	4.29	163.8	13.5	-0.39
2026-02-17	EOLS	4.39	163.8	13.3	-0.39
2026-02-18	EOLS	4.34	163.8	13.8	-0.39
2026-02-19	EOLS	4.42	163.8	-	-0.39
2026-02-20	EOLS	4.37	163.8	-	-0.39
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-23	EOLS	0.08	-9.96	13.66
2026-01-26	EOLS	0.08	-9.94	13.66
2026-01-27	EOLS	0.08	-9.94	13.66
2026-01-28	EOLS	0.08	-9.94	13.83
2026-01-29	EOLS	0.08	-9.94	13.83
2026-01-30	EOLS	0.08	-9.94	13.83
2026-02-02	EOLS	0.08	-10.11	13.83
2026-02-03	EOLS	0.08	-10.11	13.83
2026-02-04	EOLS	0.08	-10.11	13.83
2026-02-05	EOLS	0.08	-10.11	13.83
2026-02-06	EOLS	0.08	-10.11	13.83
2026-02-09	EOLS	0.08	-10.36	13.83
2026-02-10	EOLS	0.08	-10.36	13.83
2026-02-11	EOLS	0.08	-10.36	14.88
2026-02-12	EOLS	0.08	-10.36	14.88
2026-02-13	EOLS	0.08	-10.36	14.88
2026-02-17	EOLS	0.08	2.25	14.88
2026-02-18	EOLS	0.08	2.25	14.88
2026-02-19	EOLS	-0.12	2.25	14.88
2026-02-20	EOLS	-0.12	2.25	14.88
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.2

Avg. EPS Est. Current Quarter

0.06

Avg. EPS Est. Next Quarter

-0.14

Insider Transactions

-0.12

Institutional Transactions

2.25

Beta

1.02

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

75.5

Max Drawdown 5-Year %

-75.8

Target Price

14.67

P/E

Forward P/E

PEG

P/S

0.99

P/B

P/Free Cash Flow

EPS

-0.91

Average EPS Est. Cur. Y

-0.39

EPS Next Y. (Est.)

-0.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-20.49

Relative Volume

0.38

Return on Equity vs Sector %

174.6

Return on Equity vs Industry %

196.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Evolus, Inc. Common Stock

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 329

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

stock quote shares EOLS – Evolus, Inc. Stock Price stock today

news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch EOLS – Evolus, Inc. yahoo finance google finance

stock history EOLS – Evolus, Inc. invest stock market

stock prices EOLS premarket after hours

ticker EOLS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: EOLS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y